Pfizer Inc PFE

$27.54 -0.52 (-1.85%)

Valuation

Market cap
159,937,904,000
Revenue TTM
$62,579,000,000
Net income TTM
$7,771,000,000
P/E (trailing)
9.33
P/E (forward)
9.36
Profit margin
12.42%
Debt to equity
0.70

Trading

Volume
35,531,200
Avg volume
33,794,500
Day's range
$27.44 – $27.99
Shares out
5,699,854,000
Stochastic %K
4%
Beta
0.31
Analysts
Hold
Price target
$30.56

Price

Company profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under...

Show more

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
212 733 2323
Website
https://www.pfizer.com
Address
66 Hudson Boulevard East, New York, United States

Latest news

Stocktwits

Techdamentals Nov 20, 1:27 AM
One number from $PFE's latest report: revenue was $16.58 billion in the quarter ended September 27, 2026, down 0.4% from $16.65 billion a year earlier. Without Covid products Comirnaty and Paxlovid, revenue grew 7% excluding currency swings. The card lays out revenue, margins, cash and debt from the company's own reported numbers, so see the fundamentals and sign up for free. Educational, not advice. See the fundamentals below 👇 https://techdamentals.com/v3/PFE?ref=st
0 replies
TalkMarkets Nov 19, 11:36 PM
Where To Park Cash Right Now $PFE $UPS $JD $MCD https://talkmarkets.com/article/where-to-park-cash-right-now
0 replies
marketlimit Nov 19, 9:49 PM
$PFE $21 soon… before Christmas? Let me know in the comments.
0 replies
GridironGainz Nov 19, 9:38 PM 0 replies
jrh34 Nov 19, 9:24 PM
$PFE approaching oversold as RSI nears 30.
1 replies
GridironGainz Nov 19, 8:50 PM 0 replies
karpy Nov 19, 8:45 PM 0 replies
nimii Nov 19, 8:13 PM
$PFE 😡🤬😾
0 replies